Oculus OCLS Stock up on Medicare News

September 10, 2009 - Shares of Oculus Innovative Sciences, Inc (OCLS) just popped about 10 minutes ago after the company has released positive medicare news on their skin wound gel. OCLS stock is trading at $2.92 Up 13%.

Oculus Innovative Sciences Receives Medicare HCPCS Code for Reimbursement of Microcyn® Skin & Wound HydroGel

Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, announced today that Noridian Administrative Services LLC, which is the pricing, data analysis and coding contractor for the Medicare program with respect to durable medical equipment, prosthetics, orthotics, and medical supplies, has assigned a Medicare HCPCS code for Oculus' recently introduced Microcyn Skin & Wound HydroGel.

The HCPCS code #A6248 provides for 80% reimbursement of $17.05 per ounce. Reimbursement is provided for up to three ounces per month per patient wound. Full Article

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free